FEMY (Femasys) Float Percentage Of Total Shares Outstanding: 95.44% (As of Jul. 01, 2026)


FEMY Femasys Inc FEMY
55 GF Score
Price $4.17
GF Value $12.19
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Femasys Float Percentage Of Total Shares Outstanding?

Femasys FEMY +10.14% 55 Float Percentage Of Total Shares Outstanding is 95.44% as of Jul. 01, 2026. GuruFocus rates FEMY with a GF Score™ of 55/100 and a GF Value™ of $12.19 (Possible Value Trap). The stock has 7 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Femasys's float shares is 2.88 Mil. Femasys's total shares outstanding is 3.02 Mil. Femasys's float percentage of total shares outstanding is 95.44%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Femasys's Insider Ownership is 3.39%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Femasys's Institutional Ownership is 18.05%.

FEMY
55GF Score
Femasys Inc FEMY
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Femasys Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Femasys's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=2.88/3.02
=95.44%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 95.44% mean?
Femasys (FEMY) has a Float Percentage Of Total Shares Outstanding of 95.44% as of Jul. 01, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Femasys and its competitors.
Is Femasys' Float Percentage Of Total Shares Outstanding too high?
Femasys' current Float Percentage Of Total Shares Outstanding is 95.44%. Overall, Femasys has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Femasys' Float Percentage Of Total Shares Outstanding compare to UEEC and BNGO?
Femasys' Float Percentage Of Total Shares Outstanding of 95.44% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Medical Devices & Instruments company?
A good Float Percentage Of Total Shares Outstanding depends on the Medical Devices & Instruments industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Femasys and its competitors. Femasys's current Float Percentage Of Total Shares Outstanding is 95.44%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Femasys stock overvalued right now?
Based on GuruFocus' analysis, Femasys (FEMY) is currently considered Possible Value Trap. The stock's GF Value™ is $12.19, compared to a current price of $4.17 — trading 65.8% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 95.44%. Femasys' overall GF Score™ is 55/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Femasys (FEMY), the current Float Percentage Of Total Shares Outstanding is 95.44% as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Femasys (FEMY) Overvalued in 2026?

Based on GuruFocus' analysis, Femasys stock appears to be undervalued. The current stock price of $4.17 is trading 65.8% below its estimated GF Value™ of $12.19. GuruFocus considers Femasys to be Possible Value Trap.

Key valuation signals for FEMY:

  • Float Percentage Of Total Shares Outstanding: 95.44%
  • GF Value™: $12.19 vs. price of $4.17 (65.8% below fair value)
  • GF Score™: 55/100 with 7 warning signs

No single metric tells the full story. See the FEMY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Femasys Business Description

Address 3950 Johns Creek Court, Suite 100, Suwanee, GA, USA, 30024
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
55GF Score

Get the complete analysis for FEMY

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.17
Price
$12.19
GF Value